This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Exploring Rocklatan's potential in treating Glaucoma with a prescribing physician

Ticker(s): AERI

Who's the expert?

An ophthalmologist who has experience prescribing Roclatan.

Interview Questions
Q1.

Please describe your clinical practice; how many patients with glaucoma do you currently manage?

Added By: c_admin
Q2.

What has been your experience with Rocklatan to date? How many patients have you treated with this therapy?

Added By: c_admin
Q3.

  • To the extent that you have experience with patients do you see a pronounced incidence of Conjunctival hyperemia and is it something that patients understand/are comfortable with? This may be more relevant for Rhopressa. 
  • Are there any other safety issues in the profile that you are concerned about or would be concerned about if they manifested at higher than expected rates in practice? 

Added By: c_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.